THE GLOBAL mBC VISION 2025 PRELIMINARY CALL-TO-ACTION HELPED FORM THE FOUNDATION OF A GLOBAL CHARTER
First steps to improving metastatic breast cancer (mBC) patient care by 2025
The "Global Status of mBC Decade Report" laid the foundation for a 2016 collaboration with European School of Oncology (ESO) and Pfizer that fostered the development of a preliminary Call-to-Action. Comprised of ten distinct goals, the Call-to-Action is designed to help the fight against breast cancer around the world and improve the lives of people living with mBC.
The preliminary Global mBC Vision 2025 Call-to-Action was developed to address the most pressing, pertinent, and actionable gaps that patients with advanced/mBC face. This Call-to-Action was created by a multi-stakeholder taskforce to ensure that challenges faced by mBC patients rise to the top of the healthcare agenda around the world.
This important work has been advanced by the multi-stakeholder ABC Global Alliance to form the ABC Global Charter. For more information, please click here.